Spots Global Cancer Trial Database for pictilisib
Every month we try and update this database with for pictilisib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors | NCT00996892 | Solid Tumors | Cobimetinib Pictilisib | 18 Years - | Genentech, Inc. | |
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer | NCT01493843 | Non-Small Cell ... | pictilisib Placebo bevacizumab carboplatin paclitaxel | 18 Years - | Genentech, Inc. | |
Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors | NCT00996892 | Solid Tumors | Cobimetinib Pictilisib | 18 Years - | Genentech, Inc. | |
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer | NCT01493843 | Non-Small Cell ... | pictilisib Placebo bevacizumab carboplatin paclitaxel | 18 Years - | Genentech, Inc. | |
A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer | NCT00960960 | Breast Cancer | Bevacizumab Pictilisib Letrozole Paclitaxel Trastuzumab | 18 Years - | Genentech, Inc. |